Intended for healthcare professionals


Cystic fibrosis: NHS England strikes deal to offer triple combination treatment

BMJ 2020; 370 doi: (Published 01 July 2020) Cite this as: BMJ 2020;370:m2643
  1. Gareth Iacobucci
  1. The BMJ

NHS England has announced that patients with cystic fibrosis will be able to access triple combination treatment after it struck a deal with Vertex Pharmaceuticals.

The deal to offer Kaftrio was announced by NHS England (NHSE) chief executive Simon Stevens on 30 June, ahead of a licence for the treatment being granted by the European Medicines Agency in the coming weeks.

NHSE said three in five patients with cystic fibrosis could benefit from the new triple combination treatment. …

View Full Text

Log in

Log in through your institution


* For online subscription